메뉴 건너뛰기




Volumn 12, Issue 6, 2012, Pages 484-488

A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients

Author keywords

ADRB2; adrenergic beta 2 receptor agonists; indacaterol; pharmacogenetics

Indexed keywords

ARGININE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; INDACATEROL; ISOLEUCINE; PLACEBO; SALMETEROL; THREONINE; TIOTROPIUM BROMIDE;

EID: 84870059111     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2011.54     Document Type: Article
Times cited : (15)

References (16)
  • 1
    • 34548720439 scopus 로고    scopus 로고
    • Pharmacogenetics of the response to beta 2 agonist drugs: A systematic overview of the field
    • Contopoulos-Ioannidis DG, Kouri I, Ioannidis JP. Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field. Pharmacogenomics 2007; 8: 933-958.
    • (2007) Pharmacogenomics , vol.8 , pp. 933-958
    • Contopoulos-Ioannidis, D.G.1    Kouri, I.2    Ioannidis, J.P.3
  • 3
    • 0033841788 scopus 로고    scopus 로고
    • Asthma exacerbations during long term beta agonist use: Influence of beta(2) adrenoceptor polymorphism
    • Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 2000; 55: 762-767.
    • (2000) Thorax , vol.55 , pp. 762-767
    • Taylor, D.R.1    Drazen, J.M.2    Herbison, G.P.3    Yandava, C.N.4    Hancox, R.J.5    Town, G.I.6
  • 4
    • 6944232728 scopus 로고    scopus 로고
    • Use of regularly scheduled albuterol treatment in asthma: Genotypestratified, randomised, placebo-controlled cross-over trial
    • Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ et al. Use of regularly scheduled albuterol treatment in asthma: genotypestratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364: 1505-1512.
    • (2004) Lancet , vol.364 , pp. 1505-1512
    • Israel, E.1    Chinchilli, V.M.2    Ford, J.G.3    Boushey, H.A.4    Cherniack, R.5    Craig, T.J.6
  • 5
    • 0031466866 scopus 로고    scopus 로고
    • Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing
    • Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-3188.
    • (1997) J Clin Invest , vol.100 , pp. 3184-3188
    • Martinez, F.D.1    Graves, P.E.2    Baldini, M.3    Solomon, S.4    Erickson, R.5
  • 6
    • 20144363204 scopus 로고    scopus 로고
    • Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma
    • Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005; 171: 563-570.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 563-570
    • Choudhry, S.1    Ung, N.2    Avila, P.C.3    Ziv, E.4    Nazario, S.5    Casal, J.6
  • 10
    • 37349091262 scopus 로고    scopus 로고
    • Effect of ADRB2 polymorphisms on response to long acting beta2-agonist therapy: A pharmacogenetic analysis of two randomised studies
    • Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to long acting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 2007; 370: 2118-2125.
    • (2007) Lancet , vol.370 , pp. 2118-2125
    • Bleecker, E.R.1    Postma, D.S.2    Lawrance, R.M.3    Meyers, D.A.4    Ambrose, H.J.5    Goldman, M.6
  • 11
    • 60649118728 scopus 로고    scopus 로고
    • Genetic association analysis of COPD candidate genes with bronchodilator responsiveness
    • Kim WJ, Hersh CP, DeMeo DL, Reilly JJ, Silverman EK. Genetic association analysis of COPD candidate genes with bronchodilator responsiveness. Respir Med 2009; 103: 552-557.
    • (2009) Respir Med , vol.103 , pp. 552-557
    • Kim, W.J.1    Hersh, C.P.2    Demeo, D.L.3    Reilly, J.J.4    Silverman, E.K.5
  • 12
    • 50249109629 scopus 로고    scopus 로고
    • Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD
    • Mokry M, Joppa P, Slaba E, Zidzik J, Habalova V, Kluchova Z et al. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD. Med Sci Monit 2008; 14: CR392-CR398.
    • (2008) Med Sci Monit , vol.14
    • Mokry, M.1    Joppa, P.2    Slaba, E.3    Zidzik, J.4    Habalova, V.5    Kluchova, Z.6
  • 13
    • 36349014174 scopus 로고    scopus 로고
    • Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD
    • Hizawa N, Makita H, Nasuhara Y, Betsuyaku T, Itoh Y, Nagai K et al. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest 2007; 132: 1485-1492.
    • (2007) Chest , vol.132 , pp. 1485-1492
    • Hizawa, N.1    Makita, H.2    Nasuhara, Y.3    Betsuyaku, T.4    Itoh, Y.5    Nagai, K.6
  • 14
    • 55949113807 scopus 로고    scopus 로고
    • Lung function response to 12-week treatment with combined inhalation of longacting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease
    • Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H et al. Lung function response to 12-week treatment with combined inhalation of longacting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung 2008; 186: 381-386.
    • (2008) Lung , vol.186 , pp. 381-386
    • Kim, W.J.1    Oh, Y.M.2    Sung, J.3    Kim, T.H.4    Huh, J.W.5    Jung, H.6
  • 16
    • 79953026850 scopus 로고    scopus 로고
    • Once-daily indacaterol versus twice-daily salmeterol for COPD: A placebo-controlled comparison
    • Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C et al. Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J 2011; 37: 273-279.
    • (2011) Eur Respir J , vol.37 , pp. 273-279
    • Kornmann, O.1    Dahl, R.2    Centanni, S.3    Dogra, A.4    Owen, R.5    Lassen, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.